Cargando…

Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive

Detalles Bibliográficos
Autores principales:	Takahara, Mitsuyoshi, Iida, Osamu, Soga, Yoshimitsu, Kawasaki, Daizo, Fujihara, Masahiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439175/ https://www.ncbi.nlm.nih.gov/pubmed/30737654 http://dx.doi.org/10.1007/s12928-019-00573-1

Ejemplares similares

Association of Age with Mortality Rate after Femoropopliteal Endovascular Therapy for Intermittent Claudication
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

Association of Smoking, Diabetes, and Dialysis with the Presence of Popliteal Lesions in Femoropopliteal Artery Disease
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)

Inverse association of diabetes and dialysis with the severity of femoropopliteal lesions and chronic total occlusion: a cross-sectional study of 2056 cases
por: Takahara, Mitsuyoshi, et al.
Publicado: (2020)

One-Year Late Lumen Loss between A Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) and a Polymer-Free Paclitaxel-Coated Stent (Zilver PTX) for Femoropopliteal Disease
por: Soga, Yoshimitsu, et al.
Publicado: (2020)

Vessel Patency and Associated Factors of Drug‐Coated Balloon for Femoropopliteal Lesion
por: Soga, Yoshimitsu, et al.
Publicado: (2022)

Subintimal Versus Intraluminal Approach for Femoropopliteal Chronic Total Occlusions Treated With Intravascular Ultrasound Guidance
por: Tomoi, Yusuke, et al.
Publicado: (2021)

Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)

Impact of postprocedural minimum lumen area on clinical outcome after femoropopliteal drug-eluting stent implantation
por: Haraguchi, Takuya, et al.
Publicado: (2023)

Application of first-generation high- and low-dose drug-coated balloons to the femoropopliteal artery disease: a sub-analysis of the POPCORN registry
por: Fujihara, Masahiko, et al.
Publicado: (2023)

Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease
por: Soga, Yoshimitsu, et al.
Publicado: (2022)

Prognostic Value of the CHA (2) DS (2) -VASc Score after Endovascular Therapy for Femoral Popliteal Artery Lesions
por: Tomoi, Yusuke, et al.
Publicado: (2021)

Clinical Impact of Additional Cilostazol Treatment on Restenosis Risk following Heparin-Bonded Stent Graft Implantation: Sub-Analysis from the Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study
por: Tobita, Kazuki, et al.
Publicado: (2023)

One-Year Clinical Outcomes following Implantation of Innova™ Self-Expanding Nitinol Stents in Patients with Peripheral Artery Diseases Presenting Femoropopliteal Artery Lesions
por: Tsujimura, Takuya, et al.
Publicado: (2019)

Presentation Pattern of Lower Extremity Endovascular Intervention versus Percutaneous Coronary Intervention
por: Takahara, Mitsuyoshi, et al.
Publicado: (2020)

Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases
por: Takahara, Mitsuyoshi, et al.
Publicado: (2019)

Ambulatory Status Over Time after Revascularization in Patients with Chronic Limb-Threatening Ischemia
por: Kodama, Akio, et al.
Publicado: (2022)

Impact of homocysteine levels on mortality risk in patients with chronic limb-threatening ischemia undergoing revascularization
por: Takahara, Mitsuyoshi, et al.
Publicado: (2021)

Safety of paclitaxel-coated devices in the femoropopliteal arteries: A systematic review and meta-analysis
por: Zhang, Chenyang, et al.
Publicado: (2022)

Clinical Impact of Measures for Frailty Severity in Poor-Risk Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

24-Month Efficacy and Safety Results from Japanese Patients in the IMPERIAL Randomized Study of the Eluvia Drug-Eluting Stent and the Zilver PTX Drug-Coated Stent
por: Iida, Osamu, et al.
Publicado: (2021)

Combination of Rotational Atherothrombectomy and Paclitaxel-Coated Angioplasty for Femoropopliteal Occlusion
por: Scheer, F, et al.
Publicado: (2015)

In-Hospital Outcomes after Endovascular Therapy for Acute Limb Ischemia: A Report from a Japanese Nationwide Registry [J-EVT Registry]
por: Tsujimura, Takuya, et al.
Publicado: (2021)

Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study (Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia)
por: Iida, Osamu, et al.
Publicado: (2017)

The Association of Preoperative Characteristics with Reintervention Risk in Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia
por: Iida, Osamu, et al.
Publicado: (2021)

Current and Past Obesity in Japanese Patients with Critical Limb Ischemia Undergoing Revascularization
por: Takahara, Mitsuyoshi, et al.
Publicado: (2021)

Social isolation in patients with chronic limb-threatening ischemia: a cross-sectional study
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)

Injury Precipitating Tissue Loss and Time to Referral to a Vascular Center in Patients with Chronic Limb-Threatening Ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)

Association of mortality with drug-coated devices in femoropopliteal artery based on the nationwide data
por: Choi, Hyunsook, et al.
Publicado: (2021)

Assessment of Mortality and Factors Affecting Outcome of Use of Paclitaxel-Coated Stents and Bare Metal Stents in Femoropopliteal PAD
por: Falkowski, Aleksander, et al.
Publicado: (2020)

Intravascular ultrasound-based decision tree model for the optimal endovascular treatment strategy selection of femoropopliteal artery disease—results from the ONION Study-
por: Yazu, Yuko, et al.
Publicado: (2022)

Impact of Peak Systolic Velocity Ratio after Drug-Coated Balloon for Femoropopliteal Disease: Three-Month Serial Observation Vessel Echo Study
por: Kawasaki, Daizo, et al.
Publicado: (2022)

Heterogeneity of Age and Its Associated Features in Patients with Critical Limb Ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2020)

Clinical impact and risk stratification of balloon angioplasty for femoropopliteal disease in nitinol stenting era: Retrospective multicenter study using propensity score matching analysis
por: Tsuchiya, Taketsugu, et al.
Publicado: (2016)

The rewarming benefit of anterior torso heat pad application in mildly hypothermic conscious adult trauma patients remains inconclusive
por: Ting, Joseph Yuk Sang
Publicado: (2012)

Comparison between paclitaxel-coated balloon and standard uncoated balloon in the treatment of femoropopliteal long lesions in diabetics
por: Du, Xin, et al.
Publicado: (2019)

Paclitaxel and mortality in patients with claudication and de novo femoropopliteal lesions: a historical cohort study
por: Gahide, Gérald, et al.
Publicado: (2021)

Retrospective multicenter registry for endovascular treatment with newer devices in over 25‐cm femoropopliteal artery disease: A retrospective observational study
por: Horie, Kazunori, et al.
Publicado: (2022)

Duration from Wound Occurrence to Referral to a Vascular Center in Japanese Patients with Critical Limb Ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2020)

Impact of Postoperative Lumen Gain on the Reduction of Restenosis Risk after Endovascular Treatment using Drug-coated Balloon for Femoropopliteal Lesions Assessed by Intravascular Ultrasound
por: Horie, Kazunori, et al.
Publicado: (2023)

Clinical outcome of drug-coated balloons in patients with femoropopliteal chronic total occlusive lesions: results from the multicenter EAGLE study
por: Hayakawa, Naoki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8oe40mr7af9bjlla4shc8eeu81